stockrowIngevity Corporation
NGVT Basic Materials Specialty Chemicals
Ingevity Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 2.71% from fiscal 2024.
- Revenue
- −5.25%
- EPS
- +125.4%
- Free cash flow
- −136.1%
- Total debt
- −14.5%
Quarter to June 2026, against a year earlier
Follow NGVT
Alert me
Ingevity Corporation (NGVT) EBITDA
Ingevity Corporation's EBITDA for fiscal 2025 was $246.2M, down 40.7% from $414.9M in fiscal 2024. Over the twelve months to 30 June 2026 it was $237.9M. Over the past ten years it has ranged from $140.5M (fiscal 2016) to $431.0M (fiscal 2022); the current reading is higher than 36% of that period. Ingevity Corporation ranks 27th of 59 Specialty Chemicals companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $246.2M | (40.66%) |
| FY2024 | $414.9M | 28.21% |
| FY2023 | $323.6M | (24.92%) |
| FY2022 | $431.0M | 7.67% |
| FY2021 | $400.3M | 7.20% |
| FY2020 | $373.4M | 5.04% |
| FY2019 | $355.5M | 14.83% |
| FY2018 | $309.6M | 33.74% |
| FY2017 | $231.5M | 64.77% |
| FY2016 | $140.5M | (26.13%) |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $82.1M | (9.98%) |
| Mar 2026 | $91.2M | — |
| Dec 2025 | −$45.2M | — |
| Sep 2025 | $109.8M | 14.85% |
| 42 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| FUL H. B. Fuller Company compare | $564.5M |
| KWR Quaker Houghton compare | $255.7M |
| NGVT Ingevity Corporation | $237.9M |
| CC The Chemours Company compare | $217.0M |
| IOSP Innospec Inc. compare | $184.5M |
| HWKN Hawkins, Inc. compare | $181.8M |
| WDFC WD-40 Company compare | $119.3M |
| MTX Minerals Technologies Inc. compare | $73.0M |
| STDN Standard Nuclear Inc compare | — |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on NGVT
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement